Juvenile Myelomonocytic Leukemia — Trials

Juvenile Myelomonocytic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

58 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 14
Recruiting: 9
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Masonic Cancer Center, University of Minnesota
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02061800	CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant	unknown	Phase 1 / Phase 2	14	Diane GeorgeOTHER	1	Jun 4, 2024	clinicaltrials

Data updated 23 days agoSource updated Jun 4, 2024source: clinicaltrials